Diamond Pharma Services Revenue and Competitors

Harlow, UK

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Diamond Pharma Services's estimated annual revenue is currently $7.6M per year.(i)
  • Diamond Pharma Services's estimated revenue per employee is $155,000

Employee Data

  • Diamond Pharma Services has 49 Employees.(i)
  • Diamond Pharma Services grew their employee count by -37% last year.

Diamond Pharma Services's People

NameTitleEmail/Phone
1
Pharmacovigilance OfficerReveal Email/Phone
2
Pharmacovigilance OfficerReveal Email/Phone
3
Pharmacovigilance Officer (Clinical Trials)Reveal Email/Phone
4
Scientific OfficerReveal Email/Phone
5
Director - Ireland, EEA QPPVReveal Email/Phone
6
Managing DirectorReveal Email/Phone
7
Senior PV officerReveal Email/Phone
8
Regulatory Affairs OfficerReveal Email/Phone
9
PV Support OfficerReveal Email/Phone
10
Senior Pharmacovigilance Officer IIReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.5M29-12%N/AN/A
#2
$15.7M1015%N/AN/A
#3
$87.9M40525%$292MN/A
#4
$2.6M47016%$631.7MN/A
#5
$14.9M96-8%$81MN/A
#6
$44.8M2310%$132.9MN/A
#7
$7.6M49-37%N/AN/A
#8
$17.4M11212%N/AN/A
#9
$334.6M134911%£994.6MN/A
#10
$830.2M53568%N/AN/A
Add Company

What Is Diamond Pharma Services?

Diamond Pharma Services is a leading technical and scientific consulting group serving the biotechnology and pharmaceutical industry with a Global HQ in the UK and EU HQ in The Netherlands. Our emphasis is on the following areas: Regulatory Affairs: From Product Concept to Registration and Beyond Product Development: Nonclinical, CMC and Clinical Aspects Pharmacovigilance: Clinical trial (Phase I-IV), Post-Marketing and QPPV Services Compliance: GLP, GMP, GCP and QP Services Patient Information Leaflet Testing: Over 120 Tested with 100% Positive Agency Feedback Our clients range from virtual start-up companies to the largest multi-national corporations. Our expertise includes products of recombinant DNA and hybridoma technology, nucleotide based products (RNA and DNA), synthetic peptides, chemical entities (innovative and generic), vaccines (therapeutic and prophylactic), blood products and advanced therapy medicinal products (gene therapy products). We have sophisticated and well-equipped office facilities and a state-of-the-art IT system. Our IT system includes a fully validated in-house eCTD system (Extedo) and safety database (ARISg). The company was founded in 2005 by Dr. Maureen Graham, formerly Director of Regulatory Affairs at Amgen. Our specialised team of more than 50 professionals includes those with a broad and varied industry experience and former regulators, offering both breadth and depth of expertise, from which our clients can benefit.

keywords:N/A

N/A

Total Funding

49

Number of Employees

$7.6M

Revenue (est)

-37%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Diamond Pharma Services News

2022-04-13 - Fierce Biotech Layoff Tracker: Layoffs hit small biotechs Black ...

NEW—April 25, 2022: Black Diamond Therapeutics: After initially de-prioritizing ... Sanofi: The French pharma disclosed in a New York Worker...

2019-09-03 - Diamond Pharma Services Named Best Specialist CRO at ...

HARLOW, England--(BUSINESS WIRE)--Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs ...

2019-09-03 - JNA Awards ceremony to be held during September Hong Kong Jewellery Fair receives strong support from table sponsorship

The sponsoring companies span from different sectors of the trade, from diamond mining, gemmology, jewellery manufacturing, retail to trade ...

2018-11-02 - Diamond Pharma Services wins both Futures and Support ...

HARLOW, England--(BUSINESS WIRE)--Diamond Pharma Services Ltd (“Diamond”), a leading technical services and regulatory affairs ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$21.9M815%N/A
#2
$22.6M110N/AN/A
#3
$25.4M1129%N/A
#4
$28.9M1156%N/A
#5
$17.7M118-6%N/A